Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
175161 | PF-06747775 | 1776112-90-3 | 98% by HNMR/HPLC | |
PF-06747775(PF06747775;CAS 1776112-90-3) is an orally available inhibitor of the epid | ||||
17031017 | PF-04995274 | 1331782-27-4 | 98% | |
PF-04995274 is a 5-HT4 receptor partial agonist. It thought to act centrally as a pro | ||||
17031016 | Pilsicainide HCl | 88069-49-2 | 98% | |
Pilsicainide, also known as SUN 1165, is a drug used clinically in Japan to treat car | ||||
17031011 | PNU-74654 | 113906-27-7 | 98% | |
PNU-75654 disrupts the Wnt signaling pathway via inhibition of the interaction (KD5 | ||||
17031005 | PACAP 1-27 | 127317-03-7 | 98% | |
Pituitary adenylate cyclase activating polypeptide (PACAP 1-27) is a potent PACAP re | ||||
17030918 | Ponesimod | 854107-55-4 | 98% | |
Ponesimod, also known as ACT-128800, is a potent, and orally active selective S1P(1) | ||||
17030916 | Pimobendan | 74150-27-9 | 98% | |
Pimobendan is a veterinary medication. Pimobendan is both a calcium sensitizer and a | ||||
17030915 | PFK-158 | 1462249-75-7 | 98% | |
PFK-158, also known as ACT-PFK-158, is an inhibitor of 6-phosphofructo-2-kinase/fruct | ||||
17030914 | PH-797804 | 586379-66-0 | 98% | |
PH-797804 is a potent and selectiove inhibitor of p38 mitogen-activated protein (MAP) | ||||
17030913 | PIK-75 | 372196-67-3 | 98% | |
PIK-75 was developed as part of a PI 3-kinase drug discovery program. PIK75 attenuate | ||||
17030912 | PF-05089771 | 1235403-62-9 | 98% | |
PF-05089771 is a Selective Nav1.7 Inhibitor (IC50 = 11 nM) that interacts with the vo | ||||
17030716 | PF-CBP1 | 98% | ||
PF-CBP1, also known as PF-06670910, is potent and highly-selective inhibitor of the b | ||||
17030708 | Piperoxan HCl | 135-87-5 | 98% | |
Piperoxan, also known as benodaine, is a drug which was the very first antihistamine | ||||
17030704 | PFI-1 | 1403764-72-6 | 98% | |
PFI-1 is a potent and highly selective protein interaction Inhibitor, which targets B | ||||
17030702 | Pirmenol | 68252-19-7 | 98% | |
Pirmenol is an antiarrhythmic agent. Pirmenol inhibits muscarinic acetylcholine recep | ||||
17030607 | Ponatinib HCl | 1114544-31-8 | 98% | |
Ponatinib, also known as AP24534 is an oral drug for the treatment of chronic myeloid | ||||
17030304 | PD-161570 | 192705-80-9 | 98% | |
PD-161570 is a selective FGFR inhibitor (IC50 values are 40, 262 and 3700 nM for FGFR | ||||
17030201 | PF-06273340 | 1402438-74-7 | 98% | |
PF-06273340 is a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor wit | ||||
17030115 | PF-8380 | 1144035-53-9 | 98% | |
PF-8380 is a potent autotaxin inhibitor with an IC(50) of 2.8 nM in isolated enzyme a | ||||
17030111 | Pleconaril | 153168-05-9 | 98% | |
Pleconaril is an antiviral drug potentially for the treatment of enterovirus infectio | ||||
17022809 | Panobinostat | 404950-80-7 | 98% | |
Panobinostat(LBH-589) is a broad-spectrum HDAC inhibitor; low nanomolar concentration | ||||
17022702 | Pelitinib | 257933-82-7 | 98% | |
Pelitinib (EKB-569; WAY-EKB 569) is a potent irreversible EGFR inhibitor with IC50 of | ||||
17022402 | PCI-34051 | 950762-95-5 | 98% | |
PCI-34051 is a potent, histone deacetylase 8 (HDAC8)-specific inhibitor with >200-fol | ||||
17021307 | Psoralen | 66-97-7 | 98% | |
Psoralen is a naturally occurring furocoumarin that intercalates with DNA, inhibiting | ||||
16122838 | P7C3-A20 | 1235481-90-9 | 98% | |
P7C3-A20 is an analogue of P7C3, and is a proneurogenic, neuroprotective agent. P7C3- | ||||
16122837 | P7C3 | 301353-96-8 | 98% | |
P7C3 is a proneurogenic, neuroprotective agent. P7C3 protects newborn neurons from ap | ||||
161227109 | 3PO | 13309-08-5 | 98% | |
3PO is a PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase) inhibitor. 3PO | ||||
161227104 | Perampanel | 380917-97-5 | 98% | |
Perampanel is an orally active, non-competitive, and selective alpha-amino-3-hydroxy- | ||||
16122795 | P5091 (P005091) | 882257-11-6 | 98% | |
P5091(P005091) is a selective and potent inhibitor of ubiquitin-specific protease 7 ( | ||||
16122793 | PYR-41 | 418805-02-4 | 98% | |
PYR-41 is the first cell-permeable inhibitor of ubiquitin-activating enzyme E1, with |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1